Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pramod K Srivastava

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Cancer Immunology Research|April 5, 2017
George Klein (1925-2016) A Prescient, Luminous VoicePramod K Srivastava
Cancer Immunity|June 19, 2003
Hypothesis: controlled necrosis as a tool for immunotherapy of human cancerPramod K Srivastava
The Journal of Clinical Investigation|March 1, 2024
Cancer neoepitopes viewed through negative selection and peripheral tolerance: a new path to cancer vaccinesPramod K Srivastava
Scientific American|July 16, 2008
New jobs for ancient chaperonesPramod K Srivastava
Cancer Immunology Research|September 6, 2015
Neoepitopes of Cancers: Looking Back, Looking AheadPramod K Srivastava
Current Oncology Reports|February 19, 2005
Immunotherapy for human cancer using heat shock protein-peptide complexesPramod K Srivastava
Current Opinion in Immunology|February 9, 2006
Therapeutic cancer vaccinesPramod K Srivastava
Cancer Immunity|August 17, 2012
Identification of chaperones as essential components of the tumor rejection moieties of cancersPramod K Srivastava
Nature Immunology|February 21, 2012
An invariant road to cross-presentationFei Duan, Pramod K Srivastava
Plos One|July 14, 2009
Modeling the repertoire of true tumor-specific MHC I epitopes in a human tumorNisheeth Srivastava, Pramod K Srivastava
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Cancer Immunology Research|April 5, 2017
George Klein (1925-2016) A Prescient, Luminous VoicePramod K Srivastava
Cancer Immunity|June 19, 2003
Hypothesis: controlled necrosis as a tool for immunotherapy of human cancerPramod K Srivastava
The Journal of Clinical Investigation|March 1, 2024
Cancer neoepitopes viewed through negative selection and peripheral tolerance: a new path to cancer vaccinesPramod K Srivastava
Scientific American|July 16, 2008
New jobs for ancient chaperonesPramod K Srivastava
Cancer Immunology Research|September 6, 2015
Neoepitopes of Cancers: Looking Back, Looking AheadPramod K Srivastava
Current Oncology Reports|February 19, 2005
Immunotherapy for human cancer using heat shock protein-peptide complexesPramod K Srivastava
Current Opinion in Immunology|February 9, 2006
Therapeutic cancer vaccinesPramod K Srivastava
Cancer Immunity|August 17, 2012
Identification of chaperones as essential components of the tumor rejection moieties of cancersPramod K Srivastava
Nature Immunology|February 21, 2012
An invariant road to cross-presentationFei Duan, Pramod K Srivastava
Plos One|July 14, 2009
Modeling the repertoire of true tumor-specific MHC I epitopes in a human tumorNisheeth Srivastava, Pramod K Srivastava
Pageof 7